INVITRO DISSOLUTION OF SOME COMMERCIALLY AVAILABLE SUSTAINED-RELEASE THEOPHYLLINE PREPARATIONS

被引：15

作者：

BUCKTON, G

GANDERTON, D

SHAH, R

机构：

来源：

INTERNATIONAL JOURNAL OF PHARMACEUTICS | 1988年 / 42卷 / 1-3期

关键词：

D O I：

10.1016/0378-5173(88)90157-3

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：35 / 39

页数：5

相关论文

共 7 条

[1] GOODMANGILMAN A, 1980, PHARM BASIS THERAPEU, P592
[2] COMPARISON STUDY OF SUSTAINED-RELEASE THEOPHYLLINE PRODUCTS - SLO-BID CAPSULES VERSUS THEO-DUR TABLETS IN 20 CHILDREN AND YOUNG-ADULTS WITH ASTHMA
HANNAWAY, PJ
HOPPER, GDK
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1986, 77 (03) : 456 - 464
[3] STUDIES ON THE DELIVERY MECHANISMS OF THEOPHYLLINE FROM A SUSTAINED-RELEASE TABLET
LAGAS, M
JONKMAN, JHG
[J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1986, 12 (04) : 489 - 506
[4] THE BIOAVAILABILITY, ABSORPTION CHARACTERISTICS AND FORMULATION OF 4 COMMERCIALLY-AVAILABLE CONTROLLED-RELEASE THEOPHYLLINE PRODUCTS
SUMMERS, RS
SUMMERS, B
RAWNSLEY, S
[J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1986, 30 (01) : 83 - 88
[5] VOGEL AI, 1972, TXB MACRO SEMIMACRO, P52
[6] RELATIONSHIP OF FORMULATION AND DOSING INTERVAL TO FLUCTUATION OF SERUM THEOPHYLLINE CONCENTRATION IN CHILDREN WITH CHRONIC ASTHMA
WEINBERGER, M
HENDELES, L
WONG, L
[J]. JOURNAL OF PEDIATRICS, 1981, 99 (01) : 145 - 152
[7] ORAL CONTROLLED DRUG ADMINISTRATION - PHARMACOKINETIC CONSIDERATIONS
WELLING, PG
[J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1983, 9 (07) : 1185 - 1225